Post: Study Coordinator – 01 Post
Research Project: “An Open Labelled Phase I Clinical Trial to Assess the Safety, Reactogenicity, Tolerability and Immunogenicity of a Tuberculosis Vaccine BBV169 (MTBVAC), in Healthy Indian Adults.”
- Version Number & Dated: 4.0; & 31 Oct 2023.
- Protocol No: BB1L/BBVI69-I/2023.
- Reference: SRC/AC-3/560/2021
- Tenure of the Post: 12 months
- Salary per Month (Consolidated): Rs. 30,000
- Qualification: M.Pharm, Pharm.D, BDS
Important Instructions:
- Applicants must note that the appointments are purely temporary, and there is no right to claim any regular appointment in NIMS.
- Other terms and conditions will be explained during the interview.
- No T.A/D.A will be provided for attending the interview or joining the post.
- The application, in the prescribed format (available for download on the website), must be submitted with attested copies of certificates supporting all information in the application.
- Last Date for Receipt of Filled-in Applications: 24-02-2024, by 4 pm.
Interview Details:
- Date of Interview: Will be communicated over phone/e-mail to shortlisted candidates only.
- Venue: Dean’s office, NIMS.
Application Submission:
- Address: Dean’s Office, Nizam’s Institute of Medical Sciences, Punjagutta, Hyderabad – 500082.
- Mention on Envelope: Notification Number and the Last Date of Application.
Note: Candidates are encouraged to carefully read the provided details and submit applications before the specified deadline.
For more articles, Kindly Click here.
For pharmaceutical jobs, follow us on LinkedIn
